$SIBN News

SI-BONE, Inc. (SIBN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

TD Cowen Maintains Buy on SI-BONE, Lowers Price Target to $18

SI-BONE, Inc. 2026 Q1 - Results - Earnings Call Presentation

SI-BONE, Inc. (SIBN) Q1 2026 Earnings Call Transcript

Truist Securities Reiterates Buy on SI-BONE, Lowers Price Target to $18

SI-BONE (NASDAQ:SIBN) Q1 2026 Earnings Beat Sparks Nearly 12% After-Market Surge

SI-BONE Raises FY2026 Sales Guidance from $228.500M-$232.500M to $230.000M-$233.000M vs $230.387M Est

SI-BONE Q1 EPS $(0.10) Beats $(0.18) Estimate, Sales $52.588M Beat $51.105M Estimate

Truist Securities Maintains Buy on SI-BONE, Lowers Price Target to $20

SI-BONE, Inc. Q4 2025 Earnings Call Summary

TD Cowen Maintains Buy on SI-BONE, Raises Price Target to $22

Truist Securities Reiterates Buy on SI-BONE, Raises Price Target to $24

Smith+Nephew, SI-BONE partner to distribute iFuse TORQ portfolio

SI-BONE shares are trading higher after the company reported better-than-expected Q4 financial results.

SI-BONE shares are trading higher after the company reported better-than-expected Q4 financial results.

SI-BONE Inc (SIBN) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Partnerships ...

SiBone Q4 Earnings Call Highlights

SI-BONE INC (NASDAQ:SIBN) Stock Surges 12% on Strong Q4 Earnings Beat and Profitability Milestones

Si-Bone: Q4 Earnings Snapshot

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance